Dr David Gatehouse

Dr Gatehouse was appointed as a member in April 2003. He has extensive experience over 25 years on the development of and application of test methods and strategies for investigating the mutagenicity of chemicals and assessment of data. He has been particularly involved in the development of bacterial assays for gene mutations. He is on the Editorial Board of the journal Mutagenesis.

Declaration Of Interests

Personal Interest

Non-personal Interest

Company

Interest

Company

Interest

Covance

GlaxoSmithKline

Salary

Consultant

Share Holder

Pension

Share Option Holder

Share Holder

NONE